We’re excited to announce that strategic medical communications consultant STRATENYM partnered with biotech marketing agency Clarity Quest to launch reinvigorated marketing messaging and a new website.
To address pharma market access challenges, STRATENYM offers end-to-end solutions to ensure that payer-focused messaging is woven through every deliverable, making the reimbursement submission process easier for developers.
“We were very happy with the team at CQ and we are thrilled with the work that has been done to our new website,” said Shawn McDonald, STRATENYM director of operations.
“Truly, your team was super organized, patient, professional, and acted as experts in their respective areas – an unbelievably smooth process with results that are beyond what we had hoped.”
Leveraging our 22 years of experience as a biotech marketing agency, we eagerly partnered to create engaging and consistent branding, redevelop their website, and reimagine their sales deck and related collateral.
“I’m so impressed with how smooth the entire process with Clarity Quest has been,” said Sabrina Smith, STRATENYM vice president and co-founder. “It’s been a pleasure working with the team and we’re thrilled with the end result.”
About STRATENYM
Founded in 2019, STRATENYM is a boutique consulting firm focused on market access and reimbursement in the pharmaceutical industry, with a strong focus on rare diseases. They have a solid track record as experts and trusted advisors and are committed to tailoring pharmaceutical communications solutions to help their clients achieve optimal reimbursement in key markets.
STRATENYM’S experts have diverse professional backgrounds, allowing them to tap into successful strategies from other fields to offer unique market access and healthcare communications solutions.
To learn more, visit www.stratenym.com.
